Clinical trial
Levetiracetam Treatment of Tardive Dyskinesia
NCT00291213 · Yale University, Other · Completed
Key facts
| NCT number | NCT00291213 |
|---|---|
| Title | Levetiracetam Treatment of Tardive Dyskinesia |
| Lead sponsor | Yale University, Other |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tardive Dyskinesia |
| Intervention type | Drug |
| Interventions | levetiracetam, placebo |
| Enrollment | 50 |
| Primary completion | Apr 1, 2006 |
| First posted | Feb 13, 2006 |
| Last update posted | Jun 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: